A Prospective, Randomized, Open-Label, Active-Controlled Study in Adult Subjects With Acute Bacterial Sinusitis Comparing the Clinical Efficacy of Telithromycin (KETEK) 800 Mg Once a Day for 5 Days Versus Amoxicillin-Clavulanic Acid (AUGMENTIN) 875/125 Mg Twice a Day for 10 Days

Trial Profile

A Prospective, Randomized, Open-Label, Active-Controlled Study in Adult Subjects With Acute Bacterial Sinusitis Comparing the Clinical Efficacy of Telithromycin (KETEK) 800 Mg Once a Day for 5 Days Versus Amoxicillin-Clavulanic Acid (AUGMENTIN) 875/125 Mg Twice a Day for 10 Days

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Amoxicillin/clavulanic acid; Telithromycin
  • Indications Acute sinusitis; Bacterial infections
  • Focus Therapeutic Use
  • Acronyms CHOOSE
  • Most Recent Events

    • 29 Sep 2009 Planned end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top